Literature DB >> 9440024

Monoclonal antibodies to growth factors and growth factor receptors: their diagnostic and therapeutic potential in brain tumors.

D M Ashley1, S K Batra, D D Bigner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9440024     DOI： 10.1023/a:1005812417638

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  95 in total

1.  Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms.

Authors:  T Yokota; D E Milenic; M Whitlow; J Schlom
Journal:  Cancer Res       Date:  1992-06-15       Impact factor: 12.701

2.  Anti-epidermal growth factor receptor monoclonal antibodies may inhibit A431 tumor cell proliferation by blocking an autocrine pathway.

Authors:  J Mendelsohn; H Masui; A Goldenberg
Journal:  Trans Assoc Am Physicians       Date:  1987

3.  Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.

Authors:  P A Humphrey; L M Gangarosa; A J Wong; G E Archer; M Lund-Johansen; R Bjerkvig; O D Laerum; H S Friedman; D D Bigner
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts.

Authors:  S A Ali; S D Warren; K Y Richter; C C Badger; J F Eary; O W Press; K A Krohn; I D Bernstein; W B Nelp
Journal:  Cancer Res       Date:  1990-02-01       Impact factor: 12.701

6.  The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies.

Authors:  K J Kim; B Li; K Houck; J Winer; N Ferrara
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

Review 7.  Tumor antigens in astrocytic gliomas.

Authors:  S N Kurpad; X G Zhao; C J Wikstrand; S K Batra; R E McLendon; D D Bigner
Journal:  Glia       Date:  1995-11       Impact factor: 7.452

8.  Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.

Authors:  P C Phillips; C Levow; M Catterall; O M Colvin; I Pastan; H Brem
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

Review 9.  The epidermal growth factor receptor as a target for therapy in breast carcinoma.

Authors:  J Baselga; J Mendelsohn
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

10.  Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells.

Authors:  S M Shamah; C D Stiles; A Guha
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272
View more
  1 in total

1.  Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.

Authors:  Syuntaro Takasu; Toshitada Takahashi; Sho Okamoto; Noboru Oriuchi; Norihisa Nakayashiki; Kenta Okamoto; Hideki Muramatsu; Takeshi Hayashi; Norimoto Nakahara; Masaaki Mizuno; Toshihiko Wakabayashi; Tetsuya Higuchi; Keigo Endo; Kenichi Kozaki; Osamu Miyaishi; Shinsuke Saga; Ryuzo Ueda; Jun Yoshida; Kazuhiro Yoshikawa
Journal:  J Neurooncol       Date:  2003-07       Impact factor: 4.130
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.